研究报告 |
|
|
|
|
STAT3基因沉默降低小鼠乳腺癌细胞的体外迁移能力 |
徐良,顾玉超,时瀚,宓文义,于文功** |
中国海洋大学医药学院 青岛 266003 |
|
STAT3 Silencing Inhibits Migration of Murine Breast Cancer Cells in vitro |
XU Liang,GU Yu-chao,SHI Han,MI Wen-yi,YU Wen-gong |
College of Medicine and Pharmaceutics Ocean University of China, Qingdao 266003,China |
[1] O’Sullivan L A, Liongue C, Lewis R S, et al. Cytokine receptor signaling through the JakStatSocs pathway in disease. Mol Immunol, 2007, 44(10): 24972506.
[2] Huang F, Tong X, Fu L, et al. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai), 2008, 40(6): 519525.
[3] Burke W M, Jin X, Lin H J, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene, 2001, 20(55): 79257934.
[4] Azare J, Leslie K, AlAhmadie H, et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol Cell Biol, 2007, 27(12): 44444453.
[5] Gao S P, Bromberg J F. Touched and moved by STAT3. Sci STKE, 2006, 343: 30.
[6] Kira M, Sano S, Takagi S, et al. STAT3 deficiency in keratinocytes leads to compromised cell migration through hyperphosphorylation of p130(cas). J Biol Chem, 2002, 277(15): 1293112936.
[7] Itoh M, Murata T, Suzuki T, et al. Requirement of STAT3 activation for maximal collagenase1 (MMP1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene, 2006, 25(8): 11951204.
[8] Silver D L, Naora H, Liu J, et al. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res, 2004, 64(10): 35503558.
[9] Zhang F, Li C, Halfter H, et al. Delineating an oncostatin Mactivated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF7 cells. Oncogene, 2003, 22(6): 894905.
[10] Ling X, Arlinghaus R B. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res, 2005, 65(7): 25322536.
[11] Ng D C, Lin B H, Lim C P, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol, 2006, 172(2): 245257.
[12] Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumor microenvironment. Nat Rev Immunol, 2007, 7(1): 4151.
[13] Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res, 2007, 13(5): 13621366.
[14] Wang T, Niu G, Kortylewski M, et al. Regulation of the innate and adaptive immune responses by Stat3 signaling in tumor cells. Nat Med, 2004, 10(1): 4854.
[15] Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med, 2005, 11(12): 13141321.
[16] Badache A, Hynes N E. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res, 2001, 61(1): 383391. |
[17] Wegiel B, Bjartell A, Culig Z, et al. Interleukin6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer, 2008, 122(7): 15211529. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|